CLASS IIDrug recall · Reported 8 Jul 2015 · FDA Enforcement Report
TPN 3:1 with lipids, Qty: 7, Base Formula Dextrose recalled by Lincare
Lincare is recalling TPN 3:1 with lipids, Qty: 7, Base Formula Dextrose 70%, Travasol 10%, Intralipid 20%, distributed in Arkansas. The recall was initiated on 28 May 2015 and the FDA has classified it as Class II.
Check your package
Lot, batch or date codesAll product compounded between May 14, 2015 and May 27, 2015
Quantity recalled4 Bags
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility: Sterility of product is not assured.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
TPN 3:1, 997 ml with lipids Bags, Qty: 7, Base Formula Dextrose 70%, Travasol 10%, Intralipid 20%, Water for Inj; Electrolytes K Acetate, Na Acetate, KCL, Na Phos, Ca Gluconate, MgSO4, NaCl, Zinc Cl; Vitamins, trace elements and medications Selenium, Copper Cl, Carnitor, Rx Only. United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200 501-227-0900.
Lack of Assurance of Sterility: Sterility of product is not assured.
Which lots are affected?
All product compounded between May 14, 2015 and May 27, 2015
Where was it sold?
United States including: Arkansas
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.